Acne
Actinic Keratosis
Aesthetics
Alopecia
Atopic Dermatitis
Buy-and-Bill
COVID-19
Case-Based Roundtable
Chronic Hand Eczema
Chronic Spontaneous Urticaria
Drug Watch
Eczema
General Dermatology
Hidradenitis Suppurativa
Melasma
NP and PA
Pediatric Dermatology
Pigmentary Disorders
Practice Management
Precision Medicine and Biologics
Prurigo Nodularis
Psoriasis
Psoriatic Arthritis
Rare Disease
Rosacea
Skin Cancer
Vitiligo
Wound Care

Collaborative Strategies for Basal Cell Carcinoma Management : Episode 1

Opinion

Video

November 4, 2024

Overview of Advanced BCC and Highlights From Panel Discussion

Author(s):

Vishal Patel, MD, FAAD, FACMS,Meenal Kheterpal, MD

Panelists discuss how advanced basal cell carcinoma (BCC) presents unique treatment challenges and examine recent developments that show promise for improving outcomes in patients with this aggressive form of skin cancer.

Video Player is loading.

Current Time 0:00

Duration 3:55

Loaded: 4.18%

Stream Type LIVE

Remaining Time 3:55

Now Viewing

EP: 1.Overview of Advanced BCC and Highlights From Panel Discussion

EP: 2.BCC Management: The Importance of Multidisciplinary Decision-Making

EP: 3.BCC Case Example: How Advanced Disease Requires Collaborative Care

EP: 4.BCC Case Management: Long-Term Goals of Treatment

EP: 5.Key Takeaways on Advanced BCC Management

EP: 6.Multidisciplinary Care for Patients With Basal Cell Carcinoma

EP: 7.Considerations for Surgical vs Nonsurgical Approaches for BCC

EP: 8.Nonsurgical Treatments for Advanced BCC Management

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe Now!

Related Videos

Current Unmet Needs and Emerging Solutions in Atopic Dermatitis Management

Implementation Factors Affecting Ruxolitinib Adoption in Pediatric Dermatology Practice

Regulatory Challenges and Clinical Differentiators for Pediatric Atopic Dermatitis Treatments

Evaluating the Impact of Topical JAK Inhibitors on Pediatric Atopic Dermatitis Guidelines

The Future of Pediatric Atopic Dermatitis Treatment and Emerging Therapies

What Lies Ahead for GPP Diagnosis and Management

Case 3: High-Risk Patient with GPP Treatment Approach

Future Directions for IL-17 Inhibitors in Psoriasis and Psoriatic Arthritis Care

Future Perspectives: Can Innovative Topical Therapies Like Ruxolitinib Reduce Systemic Treatment Dependency in Pediatric AD?

Treatment Escalation and De-escalation Strategies in Pediatric AD: Positioning Ruxolitinib Cream in Clinical Decision-Making